Trial no.:
|
PACTR202302533541102 |
Date of Approval:
|
01/02/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
A Study Of Optimum Duration Of Administration Of First Fluid Bolus in Pediatric Septic Shock: A Randomized Controlled Trial
|
Official scientific title |
A Study Of Optimum Duration Of Administration Of First Fluid Bolus in Pediatric Septic Shock: A Randomized Controlled Trial
|
Brief summary describing the background
and objectives of the trial
|
Sepsis is a leading cause of morbidity, mortality, and healthcare utilization for children worldwide. The majority of children who die of sepsis suffer from refractory shock and/or multiple organ dysfunction syndrome (MODS), with many deaths occurring within the initial 48 to 72 hours of treatment. So, early identification and appropriate resuscitation and management are therefore critical to optimize outcomes for children with sepsis. Current guidelines for septic shock in children advocate aggressive fluid resuscitation of up to 60 mL/kg boluses of 20 mL/kg each over 5–10 minutes to achieve the desired heart rate and blood pressure. The boluses are repeated until perfusion improves, unless hepatomegaly, increased work of breathing, rales, or a gallop rhythm develops. The goal of such early and rapid fluid resuscitation according to Early Goal Directed Therapy (EGDT) to obtain distinct resuscitation goals [i.e., central venous pressure (CVP) =8–12 mmHg; mean arterial pressure (MAP) =65–90 mmHg; urinary output >0.5 mL/kg/hour; central venous oxygen saturation (ScvO2) >70% within the first six hours]. Studies have shown that this aggressive approach to fluid resuscitation leads to a nine-fold reduction in mortality. Researchers have begun questioning the basics of fluid resuscitation including the need for and duration of administration of boluses. In the Fluid Expansion as Supportive Therapy [FEAST trial]. The only randomized controlled trial (RCT) published showed increased rates of hepatomegaly but not ventilation with boluses administered so quickly. Thus, there is paucity of evidence on the optimal duration of administration of fluid boluses in the first hour of fluid resuscitation. Given the background, this study is designed to address the question as to what the optimal duration/speed of first bolus fluid administration during initial resuscitation would be safe and better tolerated in children with septic shock in the initial hour of resuscitation.
The aim |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Infections and Infestations,Paediatrics |
Sub-Disease(s) or condition(s) being studied |
Pediatric Septic Shock |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/02/2023 |
Actual trial start date |
|
Anticipated date of last follow up |
31/01/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
N/A |
|